Michael E. Jung, Ph.D
Member, Scientific Advisory Board
Dr. Jung serves as Distinguished Professor of Chemistry at the University of California-Los Angeles (UCLA). Dr. Jung is recognized as a global thought leader on synthetic organic chemistry and medicinal chemistry, where his seminal contributions to drug development, particularly in the area of modulating transcription factors, are unparalleled. Among Dr. Jung’s highly recognized work are the design of two revolutionary new drugs for the treatment of metastatic prostate cancer, Enzalutamide (Xtandi) and Apalutamide (Erleada), providing options for millions of patients. Dr. Jung received his Ph.D. from Columbia University and carried out Postdoctoral studies at the ETH (Swiss Federal Institute of Technology) in Zürich.